Relationship of acute cerebral infarction with Hcy, NF-κB, and MCP-1

doi:10.3760/cma.j.issn.1007-1245.2022.07.001

Abstract

Abstract: Ischemic stroke seriously endangers human health and is the primary cause of death or disability in China. The early treatment is very important for the prognosis of ischemic stroke patients. Thrombolytic and intravascular therapies are the most effective treatment for vascular recanalization, and can save cerebral ischemic penumbra to the greatest extent, but cerebral reperfusion injury is still inevitable. The mechanism of inflammatory injury is an important part of cerebral ischemia-reperfusion injury; therefore, it is of great significance to actively reduce the excessive inflammatory reaction of ischemic brain tissue. Evidences have shown that homocysteine (Hcy), nuclear factor-κB (NF-κB), and monocyte chemotactic protein-1 (MCP-1) are closely related to acute cerebral infarction and inflammatory injury after ischemic stroke. This article reviews the research progress on the relationship of acute ischemic stroke with Hcy, NF-κB, and MCP-1, so as to provide new ideas for alleviating cerebral ischemia-reperfusion injury and improving the patients' prognosis.

Key words: Acute cerebral infarction, Inflammatory reaction, Ischemia reperfusion injury, Homocysteine, Nuclear factor-κB, Monocyte chemotactic protein-1

摘要： 缺血性卒中严重危害人类健康，是我国居民死亡或致残的首要病因，其早期干预治疗对改善患者预后极为重要。溶栓和血管内治疗为血管再通最有效的治疗方式，可最大程度挽救脑缺血半暗带，但脑再灌注损伤仍不可避免。炎症机制是脑缺血再灌注损伤的关键部分，因此积极减轻过度炎性反应意义重大。大量研究显示，同型半胱氨酸（Hcy）、核因子-κB（NF-κB）、单核细胞趋化蛋白-l（MCP-1）与急性脑梗死关系密切，与脑缺血后炎症损伤联系紧密。本文就Hcy、NF-κB、MCP-1与急性脑梗死关系的研究进展作一综述，以期为减轻脑缺血再灌注损伤、改善患者预后提供新思路。

关键词: 急性脑梗死, 炎性反应, 缺血再灌注损伤, 同型半胱氨酸, 核因子-κB, 单核细胞趋化蛋白-l

Wang Yao, He Wen. Relationship of acute cerebral infarction with Hcy, NF-κB, and MCP-1[J]. International Medicine and Health Guidance News, 2022, 28(7): 889-893.

王瑶, 贺雯. Hcy、NF-κB、MCP-1与急性脑梗死关系的研究进展[J]. 国际医药卫生导报, 2022, 28(7): 889-893.

References

[1] Wang W, Jiang B, Sun H, et al. Prevalence, incidence, and mortality of stroke in China: results from a nationwide population-based survey of 480 687 adults [J]. Circulation, 2017, 135(8): 759-771. DOI: 10.1161/CIRCULATIONAHA.116.025250.

[2] 王伯玉,刘玲玲,张勤,等.血浆凝血酶激活的纤溶抑制物和血清同型半胱氨酸在急性脑梗死中的诊断价值[J].检验医学,2020,35(7):673-675. DOI:10.3969/j.issn.1673-8640. 2020.07.010.

[3] 王楠,刘彤彤,陈晓虹.缺血性卒中患者血同型半胱氨酸与炎症因子及神经功能缺损相关性研究[J].临床军医杂志,2016,44(12):1222-1224. DOI:10.16680/j.1671-3826. 2016.12.04.

[4] 章琳琪,范天睿,初明.同型半胱氨酸化与疾病[J].生理科学进展,2019,50(1):1-9. DOI:10.3969/j.issn.0559-7765. 2019.01.001.

[5] 万晓华,金姗,王胜来,等.体检人群同型半胱氨酸与血脂水平相关性研究[J].国际检验医学杂志,2019,40(15):1817-1821. DOI:10.3969/j.issn.1673-4130.2019.15.007.

[6] Yahn GB, Abato JE, Jadavji NM. Role of vitamin B12 deficiency in ischemic stroke risk and outcome[J]. Neural Regen Res,2021,16(3):470-474. DOI: 10.4103/1673- 5374.291381.

[7] Zhao J, Li Z, Hou C, et al. Gender differences in risk factors for high plasma homocysteine levels based on a retrospective checkup cohort using a generalized estimating equation analysis[J]. Lipids Health Dis,2021,20(1):31. DOI: 10.1186/s12944-021-01459-z.

[8] 郭彩花,窦红勇,李彩兰,等.LP-PLA2、Hcy、D-D水平在急性缺血性脑卒中患者中的临床应用价值[J].检验医学与临床,2021,18(14):2104-2106. DOI:10.3969/j.issn.1672- 9455. 2021.14.033.

[9] 韩媛,王爽,黄超,等.急性缺血性脑卒中患者血清Lp-PLA2与HCY、hsCRP及生化指标的相关性分析[J].中华急诊医学杂志,2019,28(8):1026-1028. DOI:10.3760/cma.j.issn.1671-0282.2019. 08.021.

[10] 刘梅,王彬,李婕,等.血清同型半胱氨酸、C反应蛋白、低密度脂蛋白水平与缺血性卒中TOAST各亚型、预后的关系[J].标记免疫分析与临床,2020,27(4):640-644. DOI:10.11748/bjmy.issn.1006-1703.2020.04.023.

[11] 陈小冬,李祥坤,席源,等.血清NSE、HCY及8-羟基脱氧鸟苷酸在急性脑梗死患者中的表达及意义[J].重庆医学,2017,46(31):4381-4382. DOI:10.3969/j.issn.1671-8348. 2017.31.021.

[12] 程朝辉,张跃亮,黄炜,等.急性脑梗死神经功能恢复与炎症因子的关系[J].海南医学,2019,30(19):2456-2458. DOI:10.3969/j.issn.1003-6350.2019.19.003.

[13] 陈爽.同型半胱氨酸对脑缺血再灌注大鼠小胶质细胞活化和线粒体损伤的作用及p-STAT3调节机制[D].天津: 天津医科大学,2017.

[14] Zhao Y, Huang G, Chen S, et al. Homocysteine aggravates cortical neural cell injury through neuronal autophagy overactivation following rat cerebral ischemia- reperfusion [J]. Int J Mol Sci,2016,17(8):1196. DOI: 10.3390/ijms17081196.

[15] 单佳铃,程虹毓,文乐,等.TLR/MyD88/NF-κB信号通路参与不同疾病作用机制研究进展[J].中国药理学通报,2019,35(4):451-455. DOI:10.3969/j.issn.1001-1978. 2019. 04.002.

[16] 张静雯,李东芳,段文慧,等.人五聚素3可溶性CD40配体及核因子-κB与缺血性卒中的相关性研究[J].中国药物与临床,2017,17(3):338-340. DOI:10.11655/zgywylc2017. 03.009.

[17] 黄坚友,黄亮,丁建文,等.胱天蛋白酶募集域蛋白9在中重度缺血性脑卒中发病早期阶段的作用[J].中国急救医学,2021,41(4):319-323. DOI:10.3969/j.issn.1002-1949. 2021.04.009.

[18] Stephenson, Yin T, Smalstig EB, et al. Transcription factor nuclear factor-kappa B is activated in neurons after focal cerebral ischemia[J]. J Cereb Blood Flow Metab,2000,20(3):592-603. DOI:10.1097/00004647-200003000- 00017.

[19] Zhou P, Du S, Zhou L, et al. Tetramethylpyrazine2'Osodium ferulate provides neuroprotection against neuroinflammation and brain injury in MCAO/R rats by suppressing TLR-4/NF-κB signaling pathway[J]. Pharmacol Biochem Behav,2019,176: 33-42. DOI: 10.1016/j.pbb.2018.08.010.

[20] 刘莹,王力娜,崔丽丽,等.TWEAK、NF-κB在缺血性卒中大鼠脑组织的表达及氧化苦参碱对其表达的影响[J].脑与神经疾病杂志,2020,38(3):137-143.

[21] Bianconi V, Sahebkar A, Atkin SL, et al. The regulation and importance of monocyte chemoattractant protein-1[J]. Curr Opin Hematol,2018,25(1):44-51. DOI: 10.1097/MOH.0000000000000389.

[22] He X, Li DR, Cui C, et al. Clinical significance of serum MCP-1 and VE-cadherin levels in patients with acute cerebral infarction[J]. Eur Rev Med Pharmacol Sci, 2017,21(4):804-808.

[23] Bonifačić D, Toplak A, Benjak I, et al. Monocytes and monocyte chemoattractant protein 1 (MCP-1) as early predictors of disease outcome in patients with cerebral ischemic stroke[J]. Wien Klin Wochenschr,2016,128(1-2):20-27. DOI: 10.1007/s00508-015-0878-4.

[24] 李海涛,张永强,孟令弟,等.尤瑞克林联合静脉溶栓剂对急性脑梗死患者治疗效果及血清学指标的影响[J].中华老年心脑血管病杂志,2020,22(2):169-172. DOI:10.3969/j.issn.1009-0126.2020.02.015.

[25] Hughes PM, Allegrini PR, Rudin M, et al. Monocyte chemoattractant protein-1 deficiency is protective in a murine stroke model[J]. J Cereb Blood Flow Metab,2002,22(3):308-317. DOI: 10.1097/00004647-200203000- 00008.

[26] Schilling M, Strecker JK, Schäbitz WR, et al. Effects of monocyte chemoattractant protein 1 on blood-borne cell recruitment after transient focal cerebral ischemia in mice[J]. Neuroscience,2009,161(3): 806-812. DOI: 10.1016/j.neuroscience.2009.04.025.

[27] Minami M, Satoh M. Chemokines and their receptors in the brain: pathophysiological roles in ischemic brain injury[J]. Life Sci,2003,74(2-3): 321-327. DOI: 10.1016/j.lfs.2003.09.019.

[28] Ji Y, Li Y, Zhao Z, et al. Hydrogen sulfide overproduction is involved in acute ischemic cerebral injury under hyperhomocysteinemia [J]. Front Neurosci,2020,14:582851. DOI: 10.3389/fnins.2020.582851.

[29] Zeng XK, Guan YF, Remick DG, et al. Signal pathways underlying homocysteine-induced production of MCP-1 and IL-8 in cultured human whole blood[J]. Acta Pharmacol Sin,2005,26(1):85-91. DOI: 10.1111/j.1745- 7254.2005.00005.x.

[30] Wang G, Siow YL, O K. Homocysteine stimulates nuclear factor kappaB activity and monocyte chemoattractant protein-1 expression in vascular smooth-muscle cells: a possible role for protein kinase C[J]. Biochem J,2000,352(Pt 3):817-826.